Overview
Matthew Freedman is a Radiologist practicing medicine in Washington, Washington, D.c..
Dr. Freedman is highly rated in 1 condition, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, Rhabdoid Tumor, Tissue Biopsy, and Prostatectomy.
He is actively involved in clinical research, co-authoring 158 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
3800 Reservoir Rd NW, Washington, DC 20007
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Peter Choyke is a Radiologist practicing medicine in Bethesda, Maryland. Dr. Choyke is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Smoldering Multiple Myeloma, Desmoid Tumor, Von Hippel-Lindau (VHL) Syndrome, Prostatectomy, and Endoscopy.
Ifrc LLC
Ingrid Schneider is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Schneider is highly rated in 40 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Thyroid Nodule, Mikulicz Disease, and Lymphofollicular Hyperplasia.
Fairfax Radiological Consultants PLLC
Kathryn Grumbach is a Radiologist practicing medicine in Fairfax, Virginia. Dr. Grumbach is highly rated in 45 conditions, according to our data. Her clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Gallbladder Disease, and Progressive Familial Intrahepatic Cholestasis Type 3.
Frequently Asked Questions about Dr. Matthew Freedman
How do I make an appointment with Dr. Matthew Freedman?
You can book an appointment with Dr. Matthew Freedman by calling their office at 202-444-3734. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Matthew Freedman a top-rated expert for Renal Cell Carcinoma (RCC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew Freedman is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Matthew Freedman specialize in?
While Dr. Matthew Freedman is a Radiology, they have specific expertise in Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, and Tissue Biopsy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiology.
Does Dr. Matthew Freedman participate in research or clinical trials?
Yes. Dr. Matthew Freedman has published 157 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Dr. Matthew Freedman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Renal Cell Carcinoma (RCC)Dr. Freedman isDistinguished. Learn about Renal Cell Carcinoma (RCC).
- Experienced
- Neuroendocrine TumorDr. Freedman isExperienced. Learn about Neuroendocrine Tumor.
- ProstatectomyDr. Freedman isExperienced. Learn about Prostatectomy.
- Rhabdoid TumorDr. Freedman isExperienced. Learn about Rhabdoid Tumor.
- Tissue BiopsyDr. Freedman isExperienced. Learn about Tissue Biopsy.